Review
Open access
Sep 2026
p53 Co-mutations in EGFR-mutant NSCLC: biological insight and therapeutic implications.
The biological function of p53, its role in EGFR-mutant lung cancer, and the implications for current and future therapies are discussed, and a timely and cohesive synthesis of a rapidly evolving field is offered.
J. Etessami, I. Attili, P. T. Aliaga et al.
· Cancer Treatment Reviews · 0 citations